Best Building Product Companies To Watch For 2015

Best Building Product Companies To Watch For 2015: Medidata Solutions Inc.(MDSO)

Medidata Solutions, Inc. provides software-as-a-service based clinical development solutions for life science organizations worldwide. Its solutions comprise software and services that allow customers to increase the value of their development programs by designing, planning, and managing key aspects of the clinical trial process, including study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding, clinical business analytics, and data flow and interoperability. The company primarily offers Medidata Rave, a comprehensive platform for capturing and managing clinical data. It also provides Medidata CTMS, a clinical trial management solution that streamlines operational workflows; Medidata Designer, a protocol development tool that enhances the efficiency of clinical trial start-up; Medidata Insights, a busi ness analytics platform; and Medidata Balance, a randomization and trial supply management solution, which streamlines the process of developing, building, and implementing subject allocation plans. In addition, the company offers Medidata Grants Manager, an application to benchmark the investigator budgets against industry data; Medidata contract research organization (CRO) Contractor, an analytical tool for CRO outsourcing, budgeting, and negotiation; and iMedidata, a hosted portal application that allows investigative sites and sponsor study teams to start trial activities. Further, it provides hosting, support, and professional services. The company serves pharmaceutical, biotechnology, and medical device companies; academic institutions; and CROs and other entities engaged in clinical trials through a direct sales force; and through relationships with CROs and other strategic partners. The company was founded in 1999 and is headquartered! in New York, New York.

Advisors' Opinion:

• [By Jonas Elmerraji]

  Mid-cap medical software stock Medidata Solutions (MDSO) is the smallest name on today's list by far, but it's hard to ignore the technical trade that's been setting up in shares. Even though MDSO has already rallied more than 52% since the start of 2013, this name looks well positioned for some serious continuation in the New Year.

  That's because Medidata is currently forming an ascending triangle pattern, a bullish price setup that's formed by overhead resistance at $62.50 and uptrending support to the downside. Basically, as shares bounce in between those two technical price levels, they're getting squeezed closer and closer to a breakout above resistance. When that move through $62.50 happens, we've got our buy signal.

  MDSO is another name that's been showing off outsized relative strength lately. Considering the fact that the S&P look likely to show us a healthy correction sooner rather than later, positive relative strength trends are the single most important technical indicator traders can ask for right now. When the buy signal comes, I'd recommend putting a stop on the other side of the 50-day moving average.

  
  Berkshire Hathaway (BRK.A)

  Berkshire Hathaway, on the other hand, hasn't been seeing much in the way of relative strength in the last few months. Since the start of July, Berkshire's shares have only managed to gain a third of what the broad market has returned. But a breakout in shares of Warren Buffett's favorite stock means that fortunes are likely about to turn for shareholders.

  Berkshire had been forming symmetrical triangle, a pattern that's formed by converging trendlines squeezing in on the stock's price at a nearly even rate. The symmetrical triangle has less upside bias than the ascending triangle we just looked at, but the trading trigger is essentially the same -- a breakout outside of the pattern is the signal to make a move. So, share! s of Berk! shire are flashing "buy" now.

  With the brea

• [By Jake L'Ecuyer]

  Equities Trading DOWN
  Shares of Medidata Solutions (NASDAQ: MDSO) were 19.89 percent to $42.21 after the company reported downbeat quarterly results.

• [By Kevin Marder]

  Among the names, Medidata Solutions (MDSO) is a developer of clinical development software for use in the research of new medical treatments. Most Wall Street analysts forecast earnings growth of 38% in 2013 and 13% in 2014. Revenue growth over the past several quarters has been very steady, at 21%, 24%, 26%, 27% and 27%, respectively.

• [By Monica Gerson]

  Medidata Solutions (NASDAQ: MDSO) shares slipped 17.91% to $43.25 after the company reported downbeat quarterly results.

  Arotech (NASDAQ: ARTX) shares declined 10.98% to $3.97 after falling 1.55% on Monday.

source from Top Penny Stocks For 2015:http://www.seekpennystocks.com/best-building-product-companies-to-watch-for-2015-2.html